Adeno-Associated Virus Serotype 2–hCHM Subretinal Delivery to the Macula in Choroideremia
Tomás S. Alemán(Children's Hospital of Philadelphia), Albert M. Maguire(Children's Hospital of Philadelphia), Carol Weigel-DiFranco(Massachusetts Eye and Ear Infirmary), Jason Comander(Massachusetts Eye and Ear Infirmary), Bethany S. Biron(Massachusetts Eye and Ear Infirmary), Rachel M. Huckfeldt(Penn Presbyterian Medical Center), Dean Eliott(Massachusetts Eye and Ear Infirmary), Tu M. Doan(Massachusetts Eye and Ear Infirmary), Kevin Ferenchak(Mayo Clinic), Sarah McCague(Children's Hospital of Philadelphia), Eric A. Pierce(Broad Institute), Jean Bennett(Penn Presbyterian Medical Center), Jessica I. W. Morgan(Penn Presbyterian Medical Center), Grace K. Vergilio(Penn Presbyterian Medical Center), Denise J. Pearson(Penn Presbyterian Medical Center), Manzar Ashtari(California University of Pennsylvania), Daniel C. Chung(Penn Presbyterian Medical Center), Kathleen Marshall(Children's Hospital of Philadelphia), Emily Liu(University of Iowa), Xiaohong Wen(Central South University), Leona Serrano(Penn Presbyterian Medical Center)
Cited by 39
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k